Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis

Open access
Scharl, Michael, Huber, Nicole, Lang, Silvia, Fürst, Alois, Jehle, Ekkehard, Rogler, Gerhard · 2015 · Clinical and Translational Medicine

Abstract

Background: Intestinal fibrosis and subsequent stricture formation represent frequent complications of Crohn's disease (CD). In many organs, fibrosis develops as a result of epithelial to mesenchymal transition (EMT). Recent studies suggested that EMT could be involved in intestinal fibrosis as a result of chronic inflammation. Here, we investigated whether EMT might be involved in stricture formation in CD patients. Methods: Human colonic tissue specimens from fibrotic areas of 18 CD and 10 non‐IBD control patients were studied. Immunohistochemical staining of CD68 (marker for monocytes/macrophages), transforming growth factor‐β 1 (TGFβ 1), β‐catenin, SLUG, E‐.cadherin, α‐smooth muscle actin and fibroblast activation protein (FAP) were performed using standard techniques. Results: In fibrotic areas in the intestine of CD patients, a large number of CD68‐positive mononuclear cells was detectable suggesting an inflammatory character of the fibrosis. We found stronger expression of TGFβ 1, the most powerful driving force for EMT, in and around the fibrotic lesions of CD patients than in non‐IBD control patients. In CD patients membrane staining of β‐catenin was generally weaker than in control patients and more cells featured nuclear staining indicating transcriptionally active β‐catenin, in fibrotic areas. In these regions we also detected nuclear localisation of the transcription factor, SLUG, which has also been implicated in EMT pathogenesis. Adjacent to the fibrotic tissue regions, we observed high levels of FAP, a marker of reactive fibroblasts. Conclusions: We demonstrate the presence of EMT‐associated molecules in fibrotic lesions of CD patients. These findings support the hypothesis that EMT might play a role for the development of CD‐associated intestinal fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40169-015-0046-5

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 CD68-positive mononuclear cells are present in fibrotic lesions. (A) Colonic tissue specimens from CD patients with active disease feature a large amount of collagen fibers indicative for fibrosis as visualized by van-Gieson staining. (B) Same area as in (A) features strong expression of CD68, a marker of activated monocytes/macrophages. (C) Fibrotic regions in the intestine of CD patients feature strong expression of CD68. (D) Enlarged section from (C) featuring CD68-positive mononuclear cells. (E) Representative section from (C) visualizing collagen fibers by van-Gieson staining. Magnification: 10-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.
Figure 1 CD68-positive mononuclear cells are present in fibrotic lesions. (A) Colonic tissue specimens from CD patients with active disease feature a large amount of collagen fibers indicative for fibrosis as visualized by van-Gieson staining. (B) Same area as in (A) features strong expression of CD68, a marker of activated monocytes/macrophages. (C) Fibrotic regions in the intestine of CD patients feature strong expression of CD68. (D) Enlarged section from (C) featuring CD68-positive mononuclear cells. (E) Representative section from (C) visualizing collagen fibers by van-Gieson staining. Magnification: 10-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.CC BY · PubMed Central
Figure 2 Expression of TGFβ 1 in fibrotic lesions. (A + B) In representative samples from two different non-IBD control patients, the epithelial layer showed a considerable staining intensity for TGFβ1, while the staining in sub-mucosal layers was only slightly detectable. (C) In CD patients with intestinal fibrosis, expression of TGFβ1 in the epithelial layer was strongly detectable. (D-F) In fibrotic areas, sub-mucosal TGF-β1 staining is strongly detectable. Magnification: 20-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.
Figure 2 Expression of TGFβ 1 in fibrotic lesions. (A + B) In representative samples from two different non-IBD control patients, the epithelial layer showed a considerable staining intensity for TGFβ1, while the staining in sub-mucosal layers was only slightly detectable. (C) In CD patients with intestinal fibrosis, expression of TGFβ1 in the epithelial layer was strongly detectable. (D-F) In fibrotic areas, sub-mucosal TGF-β1 staining is strongly detectable. Magnification: 20-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.CC BY · PubMed Central
Figure 3 Expression of β-catenin in fibrotic lesions. (A + B) In tissue samples from non-IBD control patients, the intestinal epithelial cells featured a strong staining for β-catenin in the cell membrane (black arrows) while the nuclei did not show any significant β-catenin staining (white arrows). In sub-mucosal layers almost no β-catenin was detectable (grey arrows). (C-F) In stenotic areas of CD patients clearly more cells featured nuclear β-catenin staining (black arrows) indicating transcriptionally active, meaning nuclear, β-catenin. Magnification: 10-fold, 40-fold or 100-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.
Figure 3 Expression of β-catenin in fibrotic lesions. (A + B) In tissue samples from non-IBD control patients, the intestinal epithelial cells featured a strong staining for β-catenin in the cell membrane (black arrows) while the nuclei did not show any significant β-catenin staining (white arrows). In sub-mucosal layers almost no β-catenin was detectable (grey arrows). (C-F) In stenotic areas of CD patients clearly more cells featured nuclear β-catenin staining (black arrows) indicating transcriptionally active, meaning nuclear, β-catenin. Magnification: 10-fold, 40-fold or 100-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.CC BY · PubMed Central
Figure 4 The transcription factor SLUG is expressed in the nuclei of mesenchymal cells in fibrotic areas. (A-D) Representative images demonstrate considerable SLUG staining in fibroblast-like cells of fibrotic areas of colonic tissue specimens derived from CD patients. SLUG is visible in the nuclei of fibroblast-like cells (black arrows) indicative for transcriptionally active SLUG protein. The insert in (A) demonstrates van-Gieson staining. Magnification: 10-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.
Figure 4 The transcription factor SLUG is expressed in the nuclei of mesenchymal cells in fibrotic areas. (A-D) Representative images demonstrate considerable SLUG staining in fibroblast-like cells of fibrotic areas of colonic tissue specimens derived from CD patients. SLUG is visible in the nuclei of fibroblast-like cells (black arrows) indicative for transcriptionally active SLUG protein. The insert in (A) demonstrates van-Gieson staining. Magnification: 10-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.CC BY · PubMed Central
Figure 5 FAP expression is strongly detectable in myofibroblasts adjacent to fibrotic areas. Representative images show (A) van-Gieson staining and (B) corresponding FAP staining in fibrotic tissue samples derived from CD patients. (B-D) FAP staining is strongly detectable in myofibroblasts adjacent to the fibrotic areas (black arrows), while FAP staining in myofibroblasts within fibrotic areas is limited (white arrows). Magnification: 10-fold. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.
Figure 5 FAP expression is strongly detectable in myofibroblasts adjacent to fibrotic areas. Representative images show (A) van-Gieson staining and (B) corresponding FAP staining in fibrotic tissue samples derived from CD patients. (B-D) FAP staining is strongly detectable in myofibroblasts adjacent to the fibrotic areas (black arrows), while FAP staining in myofibroblasts within fibrotic areas is limited (white arrows). Magnification: 10-fold. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.CC BY · PubMed Central
Figure 6 Subepithelial cells in and around fibrotic areas express E-cadherin. Representative images show E-cadherin (A; C) and van-Gieson (B) staining in corresponding tissue sections. Black arrows point onto E-cadherin positive cells. Magnification: 10-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.
Figure 6 Subepithelial cells in and around fibrotic areas express E-cadherin. Representative images show E-cadherin (A; C) and van-Gieson (B) staining in corresponding tissue sections. Black arrows point onto E-cadherin positive cells. Magnification: 10-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.CC BY · PubMed Central
Figure 7 Subepithelial cells in and around fibrotic areas express α-SMA. Representative images show α-SMA (A) and van-Gieson (B) staining in corresponding tissue sections. Magnification: 10-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.
Figure 7 Subepithelial cells in and around fibrotic areas express α-SMA. Representative images show α-SMA (A) and van-Gieson (B) staining in corresponding tissue sections. Magnification: 10-fold or 40-fold, respectively. All analysed patient samples showed comparable staining characteristics when compared to samples from non-affected controls.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 118

Metadata

Authors
Scharl, M., Huber, N., Lang, S., Fürst, A., Jehle, E., & Rogler, G.
Affiliations
  • University of Zurich (CH)
  • University Hospital Zurich (CH)
  • Caritas-Krankenhaus St. Josef (DE)
  • Department of Surgery Oberschwaben‐Klinik Ravensburg Germany
Corresponding author
Scharl, Michael
Venue
Clinical and Translational Medicine
Publisher
Wiley
Published
2015-02-07
Volume
4
Issue
1
Pages
1-1
ISSN
2001-1326 (ISSN-L)
OpenAlex
W2154570785
Cited by
118
References
28
Citations by year
2026: 5 · 2025: 5 · 2024: 14 · 2023: 9 · 2022: 10 · 2021: 17 · 2020: 12 · 2019: 10 · 2018: 14 · 2017: 8 · 2016: 10 · 2015: 4
FWCI
8.20
Type
journal article
Language
en
Open access
Licence
Locations
  • Clinical and Translational Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (146204, 314730)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords
epithelial-mesenchymal transition, Crohn's disease, intestinal fibrosis, intestinal stenosis, TGF-β1, β-catenin, Slug, fibroblast activation protein, CD68, colonic inflammation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis. https://app.cochat.ai/papers/10.1186/s40169-015-0046-5
The paper
Scharl, M., Huber, N., Lang, S., Fürst, A., Jehle, E., & Rogler, G. (2015). Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis. Clinical and Translational Medicine. https://doi.org/10.1186/s40169-015-0046-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.